LINC Scotland
4
1M
4
0.14
1
- Areas of investment
Summary
LINC Scotland appeared to be the Corporate Investor, which was created in 1993. The company was established in Europe in United Kingdom. The main department of described Corporate Investor is located in the Glasgow.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the LINC Scotland, startups are often financed by Scottish Investment Bank, Braveheart Investment Group, Tweed Renaissance Investors Capital. The meaningful sponsors for the fund in investment in the same round are Scottish Investment Bank, Braveheart Investment Group, Tweed Renaissance Investors Capital. In the next rounds fund is usually obtained by Tweed Renaissance Investors Capital, Scottish Investment Bank, Sigma Capital Group.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2006. Opposing the other organizations, this LINC Scotland works on 4 percentage points less the average amount of lead investments.
Among the most successful fund investment fields, there are Internet, Local. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Exterity, Syntropharma. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.14
- Investments by industry
- Software (2)
- Information Technology (2)
- Internet (2)
- Enterprise Software (1)
- Pharmaceutical (1) Show 7 more
- Investments by region
-
- United Kingdom (3)
- France (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
- Avg. company exit year
- 5
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Syntropharma | 15 Sep 2008 | Biotechnology, Pharmaceutical | Early Stage Venture | 2M | England, United Kingdom, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.